The t:slim X2 insulin pump with Control-IQ technology uses Dexcom G6 CGM values, in conjunction with other variables such as insulin on board, to predict sensor glucose levels 30 minutes ahead and ...

Tandem Diabetes Care, Inc. TNDM presented positive real-world data, showing immediate and continued benefits across a diverse group of people using the t:slim X2 insulin pump with the Control-IQ ...

Contacts Media Contact: Steve Sabicer 714-907-6264 [email protected] Investor Contact: Susan Morrison 858-366-6900 [email protected] ...

Tandem Diabetes Care TNDM remained under pressure on Monday, after the company accounted for plans of a combined analysis of three trials of its Control-IQ technology. Tandem Diabetes Care’s ...

Tandem Diabetes Care, Inc. TNDM recently presented data on real-world use of the t:slim X2 insulin pump with Control-IQ advanced hybrid closed-loop technology at the 14th International Conference ...

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced publication by Diabetes Technology & Therapeutics of a meta-analysis of three ...

FDA approves Tandem's closed-loop artificial pancreas to automatically control insulin doses By Conor Hale Dec 16, 2019 10:35am Diabetes Digital health FDA approval medical device ...

Tandem Diabetes is also on track to launch its second-generation AID system — t:slim X2 — with Control IQ in international markets in the latter half of 2020.